Home » Newsletters » BioWorld Science

BioWorld Science

May 31, 2022

View Archived Issues

Novel tricyclic HIV-1 integrase-LEDGF/p75 allosteric inhibitors show improved antiviral activity

Discovery of novel orally bioavailable SERD with enhanced pharmacological properties

NRG Therapeutics receives Biomedical Catalyst award for neurodegenerative disorders

Glycoengineering improves the anti-inflammatory effects of small extracellular vesicles

SLC13A5 inhibitors identified at the Rosalind Franklin University of Medicine and Science

Suzhou Yabao Pharmaceutical Research and Development patents mutant LRRK2 inhibitors

New menin/MLL interaction inhibitors synthesized at Shanghai Euregen Biopharma

Boehringer Ingelheim presents new indoleamine 2,3-dioxygenase 1 inhibitors

New CD73 inhibitors patented by Humanwell Healthcare

PharmEnable and Denali Therapeutics to collaborate in neurodegenerative disease research

RAGE-silencing RNAi suppresses pulmonary allergic inflammation

Cytoplasmic RNA vector expressing anti-CD81 antibodies suppresses experimental arthritis

Studies identify chronic pain mechanisms in skin and spinal cord

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...